RSS

Economist Intelligence Unit (EIU)

New innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch and inclusion on payer formularies, according to a new report released by the Economist Intelligence Unit and commissioned by PAREXEL more

News